Management Participants

  • Mr. Deep Saraf – Managing Director
  • Mr. Ashish Saraf – President - Strategic Planning and Business Development
  • Mr. Ashok Jain – Director & Chief Financial Officer
  • Ms. Ekta Soni – Associate Vice President, Investor Relations
  • Mr. Deepak Sharma – Company Secretary & Compliance Officer

Moderator

Mr. Hiral Keniya – Ernst & Young LLP

Key Financial Performance (Consolidated)

Q2 FY27 Performance

  • Revenue: INR459 crores, up 41.9% YoY from INR323 crores in Q2 FY26
  • EBITDA: INR118 crores, up 34.4% YoY
  • EBITDA Margin: 25.8% (impacted by higher inbound freight costs)
  • Profit After Tax (PAT): INR81 crores, up 51.8% YoY
  • PAT Margin: 17.6%, expanded by 114 basis points

H1 FY27 Performance

  • Revenue: INR863 crores, up 40.8% YoY
  • EBITDA: INR224 crores, up 38% YoY
  • EBITDA Margin: 26%
  • PAT: INR159 crores, up 59.2% YoY
  • PAT Margin: 18.5%, expanded by 213 basis points

Revenue Mix

  • Domestic: 39%
  • Export: 61% (serving customers in 39+ countries across Asia, Europe, U.S., South America, Middle East, and Africa)

Balance Sheet & Cash Flow

  • Inventory: INR1,000 crores as of September 30, 2026 (vs. INR728 crores in March 2026) due to early shea procurement alongside seasonal sal and mango seed procurement
  • Operating Cash Flow: Outflow of INR252 crores for H1 (timing impact from inventory build-up)
  • Net Debt-to-Equity: 0.04x (vs. 0.38x at FY26 end)
  • Cash & Cash Equivalents: INR498 crores
  • Working Capital: Funded through existing banking limits and internal resources

Other Income (H1)

  • Forex Gain: INR15 crores
  • Interest on FDR: INR10 crores

Business Highlights & Growth Drivers

  • Volume vs. Realization Growth: 85% of revenue growth came from volumes, 10-15% from price realization
  • Product Mix: Value-added products (CBE and stearin) now contribute ~75% of sales value (up from 65-70% previously)
  • Plant Utilization: ~85% on expanded capacity of 47,500 tons
  • Innovation: DSIR-certified Milcoa Innovation and Research Center developing application-specific products

Leadership Restructuring

Recent changes announced to create dedicated leadership for each business area:

  • Mr. Mudit Kumar Singh: Chairman (focus on governance and risk oversight)
  • Mr. Deep Saraf: Managing Director (operations, manufacturing, supply chain, project delivery)
  • Mrs. Vinita Saraf: President, Business Excellence and Development (processes, operational capabilities, strategic growth)
  • Mr. Ashish Saraf: President, Strategic Planning and Business Development (long-term strategy, global partnerships, new opportunities)

Growth Strategy (Four Pillars)

1. Expand capacity

2. Scale refining

3. Premiumize the mix

4. Expand globally

Expansion Projects & Capex Update

Current Capex Status

  • Total investment to date: INR70-75 crores
  • Expected additional investment in second half of FY27 and next fiscal year
  • Capital work in progress: INR27 crores

Project Timelines

  • Burkina Faso Backward Integration: Land acquired; regulatory approvals in progress; expected commissioning in Q3/Q4 FY28
  • LATAM Facility: Gradual ramp-up expected over next year; currently shipping from Indian plants
  • Debottlenecking (4,500 MTPA): Under planning for Q3 FY27
  • Solvent Fractionation Plant: In planning and engineering stage

Expected Benefits

  • Africa backward integration expected to provide 2-3% cost advantage at company level
  • New capacities typically ramp up from 40-50% utilization initially to 85-90% over 2-3 years
  • Asset turnover historically around 6x from forward integration investments

Operational Details

Capacity & Utilization

  • Current capacity: 47,500 tons at ~85% utilization
  • Debottlenecking expected to add 4,500 tons
  • Target utilization: 85-90% for existing facilities

Raw Material Costs

  • Raw material cost increased ~480 basis points YoY primarily due to higher freight costs
  • Freight cost increase attributed to global macro events (Red Sea movements, fuel prices)
  • Shea prices also impacted by 5-7% inflation

Demand Environment

  • No slowdown observed despite geopolitical situation
  • Capacities "quite booked" for the next year
  • Healthy demand across product portfolio

Q&A Session Highlights

Inventory Management

  • INR1,000 crore inventory includes shea nuts procured earlier from West African regions
  • Inventory expected to normalize through second half
  • Seasonal procurement pattern may vary year-to-year

Margin Outlook

  • EBITDA margin band of 25-27% considered reasonable
  • Modest quarter-to-quarter movements possible due to macroeconomic factors
  • Expected improvement from operating leverage as new capacities ramp up

Growth Sustainability

  • Company confident of maintaining growth trajectory
  • Growth levers include: debottlenecking, value-added product mix improvement, price benefits
  • Not providing specific numeric guidance

Receivables

  • Increased 82% from March 2026 levels due to timing of September month revenue
  • Normal payment terms of ~30 days
  • Already receiving remittances from customers

Closing Remarks

Management expressed confidence in delivering the next phase of growth with discipline, citing integrated business model, strong sourcing capabilities, growing value-added portfolio, wider global reach, and robust balance sheet as key strengths positioning the company to capture long-term opportunities in CBE and specialty fats.